1
项与 Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology) 相关的临床试验A Phase I Open-Label Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of Autologous MitoCell (Adipose-Derived Mesenchymal Stem Cells) Transplantation in Subjects With Idiopathic Parkinson's Disease
Primary Objective: To assess the safety profile of autologous MitoCell administered to subjects with idiopathic Parkinson's disease (PD)
Secondary Objective: To explore the efficacy and safety of MitoCell given as the recommended dose by stereotactic intrastriatal implantation
100 项与 Adipose derived MSCs therapy(Taiwan Mitochondrion Applied Technology) 相关的专利（医药）
